What if consciousness isn't a byproduct of complex brains, but a fundamental feature of reality itself, present, in some rudimentary form, all the way down to electrons and quarks? Philip Goff, a philosopher at Durham University and one of panpsychism's leading contemporary advocates, joins Craig Smith to make that case, arguing that modern science's founding move - separating the mathematical world physics studies from the subjective experience we know only from the inside - solved one problem while quietly creating another we've never resolved.

The conversation inevitably turns to AI: could a large language model ever be conscious? Goff's answer is a careful, well-reasoned no, not because he thinks consciousness is magical, but because his framework treats it as something closer to the physical substance of reality than an abstract computation, making him skeptical that anything resembling current AI architecture could cross that threshold. Along the way, he tackles one of the genuine open mysteries in his field: if natural selection only cares about behavior, why did evolution bother making us conscious at all, and what would it even mean to find experimental evidence for an answer.

Subscribe to Eye on A.I. for weekly conversations with the people building and deploying the future of AI.v

Eighty percent of lung cancer cases are diagnosed too late, not because the signals aren't there, but because nobody was looking at the right moment. Prashant Warier, co-founder and CEO of Qure.ai, joins Craig Smith to explain how his company is changing that using a tool most people already encounter: the routine chest X-ray. Cure's Lung Nodule Malignancy Risk Score - validated in the CREATE study - analyzes X-rays people get for unrelated reasons, identifies high-risk nodules, and flags which patients need follow-up CT scans. The result is a detection rate of 54 positive patients out of 100 flagged as high-risk, compared to the 2 out of 100 found by standard CT screening programs. That's not a marginal improvement. That's a different category of outcome.

The conversation covers the full landscape of where AI diagnostics actually stands today: the 15 million TB screening X-rays that Cure reads autonomously every year across 70 countries with no radiologist in the loop, because in many of those countries there are only two radiologists for the entire nation; the 26 FDA clearances and 200-plus published studies that underpin the company's clinical credibility; and the regulatory barriers that currently prevent patients from uploading their own scans and getting an AI read directly. Warier also makes his sharpest prediction: within 5 to 10 years, primary care will be AI-first, the first conversation you have when something feels wrong won't be with a doctor, it will be with an AI. Based on what Cure is already doing at scale today, that timeline is harder to dismiss than it might sound.

Subscribe to Eye on A.I. for weekly conversations with the people building and deploying the future of AI.

Genpact surveyed 500 senior executives to understand why companies are investing in AI but not seeing the value, and what they found was both clarifying and uncomfortable. Sanjeev Vohra, Genpact's Chief Technology and Innovation Officer, joins Craig Smith to share the results: only 12% of companies qualify as genuine AI leaders, meaning they're deploying AI in production environments, generating measurable business outcomes, and have the governance systems in place to actually assess that value. The other 88% are somewhere between experimenting and stalled, and the most common culprit isn't the technology or the C-suite. It's what Vohra and his clients call the "frozen middle", the operationally stretched middle managers who are too busy to lead the transformation and too central to the business to be bypassed.

The conversation covers the full landscape of what separates leaders from the rest: why co-pilots are a stepping stone that most companies are mistaking for the destination; why 99% of enterprises have no real AI governance program even as agents begin to proliferate; how Genpact's own CEO writing code on a Friday afternoon became the most powerful AI adoption signal in the company; and why Vohra's sharpest piece of advice is also the simplest, progress over perfection, because the companies still waiting for a complete roadmap before they start have already fallen behind. His formula for what's coming: engineers who are 10 times more productive, business professionals who are 3 times more capable, and organizations that treat that as a baseline expectation, not a stretch goal.

Subscribe to Eye on A.I. for weekly conversations with the people building and deploying the future of AI.